Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

Messenger RNA–based therapeutics and vaccines are the new hope in the fight against incurable diseases. A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the ...

A new study published on Thursday by Melbourne's Peter Doherty Institute for Infection and Immunity and RMIT University ...

Melbourne scientists may have unlocked the mystery behind common but annoying mRNA vaccine side effects — such as headaches, ...

The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...